(Q51913916)

17 April 2018

title

Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. (English)

1 reference

17 April 2018

1 reference

6

Robert E Drake

1 reference

17 April 2018

Gary A Morse

1

1 reference

17 April 2018

Robert J Calsyn

2

1 reference

17 April 2018

W Dean Klinkenberg

3

1 reference

17 April 2018

Thomas W Helminiak

4

1 reference

17 April 2018

Nancy Wolff

5

1 reference

17 April 2018

Robert D Yonker

7

1 reference

17 April 2018

Gyanesh Lama

8

1 reference

17 April 2018

Matthew R Lemming

9

1 reference

17 April 2018

Suzanne McCudden

10

1 reference

17 April 2018

publication date

4 August 2006

1 reference

17 April 2018

Community Mental Health Journal

published in

1 reference

17 April 2018

volume

42

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

377-404

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1007/s10597-006-9050-y

exact match

0 references

cites work

Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Models of community care for severe mental illness: a review of research on case management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Substance use in young adults with schizophrenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Cost-effectiveness evaluation of three approaches to case management for homeless mentally ill clients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Getting the cost right in cost-effectiveness analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Estimated societal costs of assertive community mental health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-006-9050-Y

Alcohol use and abuse in schizophrenia. A prospective community study

21 January 2018

1 reference

12 December 2020

A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill.

1 reference

12 December 2020

Impact of assertive community treatment on homeless persons with co-occurring severe psychiatric and substance use disorders.

1 reference

12 December 2020

Moving assertive community treatment into standard practice

1 reference

12 December 2020

Cost-effectiveness of assertive community treatment teams.

1 reference

12 December 2020

A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

1 reference

12 December 2020

Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness

1 reference

12 December 2020

Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care

1 reference

12 December 2020

A comparison of long-term and short-term residential treatment programs for dual diagnosis patients.

1 reference

12 December 2020

A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Substance abuse in schizophrenia: service utilization and costs

1 reference

12 December 2020

Implementing evidence-based practices in routine mental health service settings.

1 reference

12 December 2020

Program fidelity in assertive community treatment: development and use of a measure.

1 reference

12 December 2020

Cost-effective treatment for persons with dual disorders.

1 reference

12 December 2020

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

1 reference

12 December 2020

Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders

1 reference

12 December 2020

Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.

1 reference

12 December 2020

Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group.

1 reference

12 December 2020

Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study

1 reference

12 December 2020

The Dartmouth Assertive Community Treatment Scale (DACTS). A generalizability study.

1 reference

12 December 2020

Intensive case management for the severely mentally ill. Controlled trial.

1 reference

12 December 2020

Implementing dual diagnosis services for clients with severe mental illness

1 reference

12 December 2020

Integrated treatment for dually diagnosed homeless adults.

1 reference

12 December 2020

10.1007/S10597-006-9050-Y

Identifiers

DOI

1 reference

17 April 2018

Dimensions Publication ID

1036144779

0 references

1 reference

17 April 2018